Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway. Mingyuan Wu Fenggang Hou Zhaoshuo Yang Zhenfeng Zhu Yao Wang Hong Wang Jul 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 44 references Medicine DOI PubMed Semantic Scholar Save View source Cite Copy APA Copied ✓ Copy MLA Copied ✓ Copy BibTeX Copied ✓ Share